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Students’ Corner
Case Report
A case of transient diabetes insipidus following cardiopulmonary bypass
Omer Ashraf1, Hasanat Sharif2, Mansoor Shah3
Final Year Medical Student1, Departments of Surgery2 and Medicine3, The Aga Khan University Hospital, Karachi, Pakistan.

Abstract
Cardiopulmonary bypass surgery has been linked
with a number of postoperative complications. One of the
frequently reported physiological alterations is the relative
diuresis seen in the immediate post-op period. Rarely
reported though is the development of full-blown diabetes
insipidus in such patients. The etiology is unknown and has
only been hypothesized in the past. We present the clinical
course of a 54 year old male who developed transient diabetes insipidus post bypass surgery with subsequent recovery following exogenous vasopressin administration. The
physiological alteration leading to the development of diabetes insipidus in a small fraction of bypass patients remains
unknown. We propose that the variation in natriuretic peptide levels in the post-bypass period could account for the
transient event.

Introduction
Diabetes insipidus (DI) is rarely encountered after
bypass surgery. The phenomenon is poorly understood. We
present a patient who developed transient diabetes insipidus
following cardiopulmonary bypass (CPB), and hypothesize
further on the subject.

Case Report
A 54 years old male underwent an uneventful onpump total arterial revascularization procedure for three vessel coronary artery disease. The procedure lasted 107 minutes, with aortic cross clamp time of 75 minutes. The minimum temperature during the procedure was 330C.
On the first postoperative day his urinary output
increased to around 250 ml/hour. There were no clinical
signs of any other endocrine or neurological deficit and laboratory work up revealed serum electrolytes, creatinine and
urea nitrogen to be within the normal range. He was not
receiving any diuretics. Fluid replacement was initiated
while he continued to have polyuria. On the fifth postoperative day, after a provisional diagnosis of DI was made,
intranasal desmopressin (synthetic vasopressin) was initiated. His urinary output declined thereafter, taking another
two days to return to normal. Since then he has remained
symptom free with no complaints of altered urinary output,
at follow up visits.

Discussion
CPB can produce a myriad of physiologic disturbances, including altered fluid, electrolyte and acid-base
balance, renal compromise, embolic events as well as neu-
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roendocrine changes. Despite the abundance of conflicting
reports regarding the variations in antidiuretic hormone
(ADH) levels during and after CPB, DI is rarely encountered in the post-bypass patient.
While the etiology remains to be established the
pathology in this patient was seemingly ADH deficiency.
This can be established from the rapid decline in urinary
output coupled with a relative increase in its osmolality after
desmopressin administration in this patient. Classified
under central DI, a variety of causes could lower ADH levels in such patients.1
The lack of any associated neuroendocrine findings
and the transient nature of the event make a neurological
cause an improbable one. As Kuan et al2 had argued, this
appears to be more of a functional discrepancy than a morphological lesion. They attributed the polyuria to a transient
malfunction of the left atrial nonosmotic receptors for vasopressin release, owing to CPB and cold cardioplegia. This
occurred in a fraction of patients already having selective
osmoreceptor dysfunction. The time it took for the nonosmotic receptor to regain its function was the time it took for
the polyuria to diminish.
The above mentioned theory is the only formally
proposed pathogenesis regarding this subject in literature.
Whilst being plausible, it does not offer a precise explanation as to what caused the left atrial nonosmotic receptors to
lose and then recover their function in a matter of days. The
lack of evidence based medicine on the issue leaves the
room open for further hypothesis.
Volume loading during CPB results in stretching of
the cardiac myocytes. This leads to an augmentation in the
level of natriuretic peptides after CPB.3 Peaking early in the
first week4 and then gradually declining, this occurrence has
been known to be associated with post-bypass diuresis.3 The
phenomenon can result in polyuria not only through the primary action of natriuretic peptides on kidney, but also
through inhibition of the vasopressin neuraxis. This would
result in low vasopressin levels subject to correction by
exogenous vasopressin administration, as seen in this patient
as well as the three patients reported by Kuan et al.2 With the
timely decline in natriuretic peptide release, the ADH levels
would rise again and urinary output would normalize.
The physiology of natriuretic peptides is interlaced
around a number of factors. The fact that it could lead to DI
in a small fraction of patients undergoing CPB, could be due
to a selective disturbance in any one of the associated
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factors in that subset of population. Alterations in gene
expression or receptor sensitivity are possible candidates.
Further research is warranted to ascertain the above mentioned postulation and investigate the source of this suggested aberration in the natriuretic peptide physiology in a small
subset of patients undergoing cardiac surgery.

actions of the arginine vasopressin system and their variation with cardiac bypass is required before a pathogenesis is
conclusively established.
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